The relative impact of waiting time and treatment entry on drug and alcohol use

Addiction Biology
David BestJohn Strang

Abstract

One hundred and twenty-three treatment-seeking substance misusers were recruited to a study assessing the early impact of treatment. Participants were interviewed at treatment entry and 3 and 6 months later, regardless of their treatment status (i.e. including those who had dropped out of treatment), while additional data were obtained from the two assessment interviews carried out prior to the initiation of treatment. Three consistent observations can be applied to both the opiate misuser (n = 61) and problem drinker samples (n = 62): (1) the period of pre-treatment wait (mean of 8 weeks) was characterized by stable patterns of substance misuse with no significant 'spontaneous' improvement in indices of severity of drug or alcohol problems; (2) the period immediately following initiation of treatment was associated with substantial reductions in the quantity and frequency of substance use, an effect not influenced by the length of time for treatment initiation; (3) these benefits are maintained to 6 months after treatment initiation. The waiting period for treatment initiation does not seem to be characterized by significant changes in drug or alcohol use patterns, at least among those who made it into treatment, with clear an...Continue Reading

References

Mar 1, 1978·The British Journal of Addiction to Alcohol and Other Drugs·A WilsonD E Lange
Aug 1, 1976·The British Journal of Psychiatry : the Journal of Mental Science·A Robin
Jan 1, 1975·The American Journal of Drug and Alcohol Abuse·G W Joe, D D Simpson
Sep 1, 1991·American Journal of Public Health·S R YancovitzJ W Robinson
Nov 1, 1990·Drug and Alcohol Dependence·W M Addenbrooke, N H Rathod
May 13, 1989·Lancet·J F French, J Safford
Jan 1, 1989·Journal of Substance Abuse Treatment·A S FriedmanA Utada
Mar 1, 1987·Archives of General Psychiatry·T R KostenH D Kleber
Jun 1, 1985·British Journal of Addiction·G SutherlandG Edwards
Jun 1, 1983·British Journal of Addiction·T StockwellR Hodgson
Oct 12, 1984·JAMA : the Journal of the American Medical Association·J A Ewing
Jul 1, 1984·Journal of Studies on Alcohol·G LeighP Cleland
Jan 1, 1984·Soins; la revue de référence infirmière·E Guillibert
Jul 1, 1983·The International Journal of the Addictions·M HesselbrockK Workman
Mar 1, 1982·Journal of Studies on Alcohol·H M PettinatiH S Maurer
Oct 15, 1994·BMJ : British Medical Journal·M FarrellJ Strang
Feb 1, 1993·The International Journal of the Addictions·R R Reno, L S Aiken

❮ Previous
Next ❯

Citations

Dec 2, 2008·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Richard C RappRobert G Carlson
Apr 26, 2008·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Filippo PassettiColin Drummond
Nov 21, 2013·BMC Health Services Research·Rachael V PascoeNooshin Khobzi Rotondi
May 30, 2008·Journal of Drug Issues·Cristina RedkoRobert G Carlson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved